These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
124 related items for PubMed ID: 8196147
1. Drug-resistant pneumococcal infections in the United States. A problem for clinicians, laboratories, and public health. Simberkoff MS. JAMA; 1994 Jun 15; 271(23):1875-6. PubMed ID: 8196147 [No Abstract] [Full Text] [Related]
2. Emergence of drug-resistant pneumococcal infections in the United States. Breiman RF, Butler JC, Tenover FC, Elliott JA, Facklam RR. JAMA; 1994 Jun 15; 271(23):1831-5. PubMed ID: 8196139 [Abstract] [Full Text] [Related]
6. [An update of Streptococcus pneumoniae: from genomic to clinic]. Wintenberger C. Med Mal Infect; 2010 Oct 20; 40(10):605-9. PubMed ID: 20934286 [No Abstract] [Full Text] [Related]
7. Is drug resistance affecting treatment outcomes? Bishai W. Am J Manag Care; 2000 Dec 20; 6(23 Suppl):S1197-201. PubMed ID: 11187443 [Abstract] [Full Text] [Related]
8. Management of infections caused by antibiotic-resistant Streptococcus pneumoniae. Friedland IR, McCracken GH. N Engl J Med; 1994 Aug 11; 331(6):377-82. PubMed ID: 8028618 [Abstract] [Full Text] [Related]
9. Pneumococcal drug resistance: the new "special enemy of old age". Butler JC, Cetron MS. Clin Infect Dis; 1999 Apr 11; 28(4):730-5. PubMed ID: 10825028 [Abstract] [Full Text] [Related]
10. Serotype distribution and antimicrobial resistance of adult Streptococcus pneumoniae clinical isolates over the period 2001-2008 in Crete, Greece. Maraki S, Mantadakis E, Samonis G. Chemotherapy; 2010 Apr 11; 56(4):325-32. PubMed ID: 20720416 [Abstract] [Full Text] [Related]
11. [Antibacterial therapy of pneumococcal infections caused by drug resistant microorganisms]. Sidorenko SV. Antibiot Khimioter; 2002 Apr 11; 47(7):31-7. PubMed ID: 12516194 [No Abstract] [Full Text] [Related]
12. Macrolide-resistant Streptococcus pneumoniae and use of antimicrobial agents. Pihlajamäki M, Kotilainen P, Kaurila T, Klaukka T, Palva E, Huovinen P, Finnish Study Group for Antimicrobial Resistance (FiRe-Network). Clin Infect Dis; 2001 Aug 15; 33(4):483-8. PubMed ID: 11462184 [Abstract] [Full Text] [Related]
13. Resistance of S. pneumoniae to fluoroquinolines--US, 1995-1999. Ann Pharmacother; 2001 Nov 15; 35(11):1509. PubMed ID: 11724112 [No Abstract] [Full Text] [Related]
14. [Antibiotic resistance of Streptococcus pneumoniae (Pneumococcus). Epidemiologic and clinical aspects]. Kaufhold A. Med Klin (Munich); 1988 Oct 28; 83(21):723-6. PubMed ID: 3070311 [No Abstract] [Full Text] [Related]
15. [Resistant pneumococci]. Garau J, Liñares J. Med Clin (Barc); 1985 May 04; 84(17):688-90. PubMed ID: 4010372 [No Abstract] [Full Text] [Related]
16. Minimizing the impact of drug-resistant Streptococcus pneumoniae (DRSP). A strategy from the DRSP Working Group. Jernigan DB, Cetron MS, Breiman RF. JAMA; 1996 Jan 17; 275(3):206-9. PubMed ID: 8604173 [Abstract] [Full Text] [Related]
17. Resistance among Streptococcus pneumoniae: patterns, mechanisms, interpreting the breakpoints. Brueggemann AB, Doern GV. Am J Manag Care; 2000 Dec 17; 6(23 Suppl):S1189-96. PubMed ID: 11187442 [Abstract] [Full Text] [Related]
18. Antimicrobial-resistant Streptococcus pneumoniae: trends and management. Jacobs MR. Expert Rev Anti Infect Ther; 2008 Oct 17; 6(5):619-35. PubMed ID: 18847402 [Abstract] [Full Text] [Related]
19. Action plan for drug-resistant Streptococcus pneumoniae. The DRSP Working Group. Cetron MS, Jernigan DB, Breiman RF. Emerg Infect Dis; 1995 Oct 17; 1(2):64-5. PubMed ID: 8903164 [No Abstract] [Full Text] [Related]